Brainstorm Cell Therapeutics, Inc. (BCLI)
0.98
-0.08
(-7.55%)
USD |
OTCM |
Aug 21, 16:00
Brainstorm Cell Therapeutics 1 Year Total Returns (Daily) : 55.31% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 55.31% |
| August 20, 2026 | 70.97% |
| August 19, 2026 | 88.76% |
| August 18, 2026 | 127.4% |
| August 17, 2026 | 73.53% |
| August 14, 2026 | 64.04% |
| August 13, 2026 | 24.39% |
| August 12, 2026 | 37.15% |
| August 11, 2026 | 41.43% |
| August 10, 2026 | 36.23% |
| August 07, 2026 | 24.02% |
| August 06, 2026 | 31.15% |
| August 05, 2026 | 33.80% |
| August 04, 2026 | 11.96% |
| August 03, 2026 | 17.91% |
| July 31, 2026 | 26.76% |
| July 30, 2026 | 26.62% |
| July 29, 2026 | 21.03% |
| July 28, 2026 | 24.93% |
| July 27, 2026 | 30.08% |
| July 24, 2026 | 39.13% |
| July 23, 2026 | 45.99% |
| July 22, 2026 | 46.22% |
| July 21, 2026 | 24.32% |
| July 20, 2026 | 13.10% |
| Date | Value |
|---|---|
| July 17, 2026 | -77.37% |
| July 16, 2026 | -76.20% |
| July 15, 2026 | -75.44% |
| July 14, 2026 | -75.76% |
| July 13, 2026 | -73.60% |
| July 10, 2026 | -72.73% |
| July 09, 2026 | -72.98% |
| July 08, 2026 | -71.21% |
| July 07, 2026 | -68.86% |
| July 06, 2026 | -67.17% |
| July 02, 2026 | -63.64% |
| July 01, 2026 | -67.42% |
| June 30, 2026 | -74.75% |
| June 29, 2026 | -77.27% |
| June 26, 2026 | -76.52% |
| June 25, 2026 | -75.83% |
| June 24, 2026 | -76.32% |
| June 23, 2026 | -77.02% |
| June 22, 2026 | -77.27% |
| June 18, 2026 | -78.17% |
| June 17, 2026 | -78.54% |
| June 16, 2026 | -78.99% |
| June 15, 2026 | -79.57% |
| June 12, 2026 | -81.06% |
| June 11, 2026 | -80.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -47.22% |
| Summit Therapeutics, Inc. | -49.40% |
| Kezar Life Sciences, Inc. | 84.56% |
| Protara Therapeutics, Inc. | 24.19% |
| Clene, Inc. | -19.10% |